NAS:CHRS (USA)

Coherus BioSciences Inc $ 15.43 -0.3 (-1.91%)

Volume:
1,455,629
Avg Vol (1m):
1,524,659
Market Cap $:
1.12 Bil
Enterprise Value $:
996.02 Mil
PE Ratio:
9.46
PB Ratio:
4.83
Warning! GuruFocus has detected 2 Severe warning signs with CHRS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for CHRS (Coherus BioSciences Inc) from 2014 to Mar 03 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Coherus BioSciences stock (CHRS) PE ratio as of Mar 03 2021 is 9.46. More Details

Coherus BioSciences PE Ratio (TTM) Chart

EMBED

Coherus BioSciences PE Ratio (TTM) Historical Data

Total 1242
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Coherus BioSciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-03-049.5 2020-12-2810.3
2021-03-029.7 2020-12-248.5
2021-03-019.8 2020-12-238.4
2021-02-2610.0 2020-12-228.4
2021-02-259.4 2020-12-218.4
2021-02-2410.0 2020-12-188.6
2021-02-2310.0 2020-12-178.7
2021-02-2210.0 2020-12-168.5
2021-02-1910.6 2020-12-158.7
2021-02-1810.3 2020-12-148.9
2021-02-1710.6 2020-12-118.7
2021-02-1610.7 2020-12-108.8
2021-02-1511.1 2020-12-099.0
2021-02-1211.1 2020-12-089.1
2021-02-1111.6 2020-12-079.0
2021-02-1012.1 2020-12-049.3
2021-02-0912.3 2020-12-039.1
2021-02-0812.1 2020-12-029.2
2021-02-0511.0 2020-12-019.2
2021-02-0410.7 2020-11-309.1
2021-02-0310.6 2020-11-279.1
2021-02-0210.7 2020-11-258.9
2021-02-0110.8 2020-11-249.2
2021-01-2911.5 2020-11-239.1
2021-01-2811.9 2020-11-208.9
2021-01-2713.1 2020-11-198.8
2021-01-2612.5 2020-11-188.7
2021-01-2512.0 2020-11-178.7
2021-01-2211.3 2020-11-168.8
2021-01-2111.0 2020-11-138.8
2021-01-2011.2 2020-11-128.7
2021-01-1911.1 2020-11-118.9
2021-01-1510.9 2020-11-109.1
2021-01-1411.0 2020-11-098.7
2021-01-1310.6 2020-11-068.2
2021-01-1210.7 2020-11-059.0
2021-01-1110.8 2020-11-048.9
2021-01-0811.2 2020-11-038.4
2021-01-0711.0 2020-11-028.1
2021-01-0610.6 2020-10-308.2
2021-01-0510.3 2020-10-298.4
2021-01-0410.4 2020-10-288.4
2020-12-3110.7 2020-10-278.7
2020-12-3010.8 2020-10-268.7
2020-12-2910.6 2020-10-238.6

Coherus BioSciences PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 541714 NAICS : 2836
Traded in other countries CHRS.USA
Address 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065
Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.